CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
167 hedge funds and large institutions have $752M invested in Clovis Oncology, Inc. in 2019 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 72 increasing their positions, 39 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
41% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 41
80% less funds holding in top 10
Funds holding in top 10: 5 → 1 (-4)
Holders
167
Holding in Top 10
1
Calls
$69.7M
Puts
$12M
Top Buyers
| 1 | +$28.7M | |
| 2 | +$18.2M | |
| 3 | +$10.3M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$9.84M |
| 5 |
SC
Samlyn Capital
New York
|
+$8.67M |
Top Sellers
| 1 | -$52.1M | |
| 2 | -$37.2M | |
| 3 | -$20M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$16.4M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$14.9M |